Statin therapy in individuals with intermediate cardiovascular risk

As intermediate cardiovascular risk group accounts for a large part of the total population, determining appropriate cholesterol target in this population is critical. Herein, we investigated the optimal low-density lipoprotein cholesterol (LDL-C) level in individuals with intermediate cardiovascular risk after statin therapy.

https://www.metabolismjournal.com/article/S0026-0495(23)00327-X/fulltext?rss=yes

Source: Metabolism - Clinical and Experimental - November 3, 2023 Category: Biomedical Science Authors: Joongmin Kim, Hyeongsoo Kim, Sang Hyun Park, Yura Kang, Kyungdo Han, Sang-Hak Lee Source Type: research